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Abstract 2-[F-18]-fluoro-2-deoxy-
D-glucose (FDG) positron emission
tomography (PET) has become an
important staging modality for many
tumors, including bronchial carcino-
ma; however it is important to know
that there are several pitfalls in PET
image interpretation. In this report
we demonstrate three cases in which
focal intrapulmonary FDG uptake
could possibly represent iatrogenic
microembolism. These FDG accumu-
lations would have been interpreted
as malignant tumor mass in the lung
if no anatomic correlation would
have been performed. For this rea-
son, we further present an integrated
PET/CT scanner, which recently has
been introduced. This correlation of
molecular and morphological infor-
mation enables the specification of
the FDG-PET findings.
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Introduction
The 2-[F-18]-fluoro-2-deoxy-D-glucose positron emission
tomography (FDG-PET) has become an important staging
modality for many tumors including bronchial carcinoma.
It has been demonstrated that FDG-PET is more sensitive
and more specific than CT in the staging of many tumors
[1]. It identifies lesions not seen in CT and lesions which
cannot be specified as being malignant or benign based on
morphological criteria only. A major drawback of FDG-
PET is the almost complete absence of an anatomic refer-
ence frame, which often prevents the diagnostician from
being able to precisely localize disease foci with the FDG-
PET examination alone. For this reason, integrated PET/
CT scanners have been recently introduced [2, 3]. The
great advantage of these combined systems providing
“hardware” co-registered images is that lesions seen in
FDG-PET can be correlated to the morphological findings
without the additional use of complex software packages.
This correlation of molecular and morphological informa-
tion helps to specify FDG-PET findings. This is important
because it is well known that FDG not only accumulates
in many tumors but also in inflammatory tissue and a 
variety of physiological and artificial settings [4].
Herein we report on three cases where patients dem-
onstrated lung lesions on FDG-PET. It is hypothesized
that these lesions were microembolisms formed during
injection, with a size to make them lodge in the distal
capillary lung bed very much like macroaggregates of 
albumin lodge in the lung parenchyma.
Case reports
The FDG-PET/CT examinations in three patients with focal FDG
uptake in the lung were identified among 750 PET/CT scans 
performed from March until November 2001. The patients were
examined for the diagnoses discussed below.
Case 1
A 58-year-old patient had a PET/CT scan for preoperative staging
of a histologically proven non-small-cell lung cancer. This patient
underwent a second PET/CT scan 5 days after the initial scan due
to the unclear findings in the right upper lobe.
Case 2
An 11-year-old child had a PET/CT scan for re-staging after 
chemotherapy and radiotherapy of Hodgkin’s lymphoma.
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Results
The first patient showed a pathological FDG accumula-
tion in the right apical lung segment (Fig. 1) in addition
to the FDG uptake in the known tumor mass in the left
upper lobe adjacent to the aorta (Fig. 2). The co-regis-
tered unenhanced CT image (Fig. 3) corresponding to
the PET image of Fig. 1 showed no anatomical correlate
to the FDG focus, which would have suggested the pres-
ence of a pulmonary nodule. The focus projected onto a
branching point of a peripheral lung vessel. The patient
received a partially paravenous injection at the right arm
(Fig. 4). This discrepancy of findings with potentially
important clinical consequences prompted us to order a
repeat scan, which was performed 5 days after the initial
scan. While the known tumor lesion was identified
again, the focal FDG accumulation in the right apical
lung segment was not present in the second scan (Fig. 5).
The other two patients showed similar findings than the
first patient with FDG accumulation at a lung site where
no anatomic correlate could be identified (Figs. 6, 7). In
these patients no repeat scans were ordered because of
the lack of clinical consequence of these findings. 
Discussion
On the basis of the initial findings in the first patient, the
hypothesis was made that the FDG focus was due to a 
tiny blood clot possibly arising from some aspiration/
paravenous injection, which lodged in the peripheral
lung.
Inflammatory changes also show increased FDG 
uptake. Therefore, these lesions could have represented
acute inflammation; however, no morphological changes
were seen in CT used for co-registration. Also, such a
high increase in FDG uptake is rarely seen in PET imag-
ing due to inflammation and a certain degree of uptake
would have been expected in the follow-up exam after
5 days; therefore, the absence of the prominent lesion on
the second FDG PET/CT can be explained by iatrogenic
microembolism. Circumstantial evidence to this hypoth-
esis could be the high FDG concentration within the 
intrapulmonary lesion. This observation can only be ex-
plained when the thrombus formation happened within
the syringe or the site of injection as demonstrated in
Fig. 4. Iatrogenic embolization is well known as a com-
plication of permanent venous access devices [5]; how-
ever, no data are available regarding microembolism due
to peripheral venous access as used in our study. The
findings suggest that occasionally, and particularly when
FDG injection does not work flawlessly, minor blood
clots can form. The two other cases, again exhibiting a
mismatch between molecular imaging and morphologi-
cal imaging findings, could serve as corroborating 
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Case 3
A 56-year-old patient had a follow up PET/CT scan after surgical
resection of a non-small-cell lung cancer.
Four PET/CT scans were performed on the three patients using
a novel combined PET/CT system (Discovery LS, GE Medical
Systems, Waukesha, Wis.), combining the ability to acquire CT im-
ages and PET data of the same patient in “hardware” co-registered
fashion in one session. The Discovery LS system consists of a GE
Advance NXi PET and a multislice helical CT (LightSpeed plus)
scanner. The axes of both systems are mechanically aligned to co-
incide perfectly. Initially, 1000 ml of oral contrast (Micropaque
scanner, Guerbet, Aulnay-sous-Bois, France) was given for delin-
eation of intestinal structures. Sixty to 120 min after intravenous
injection of 10 mCi of FDG, the PET/CT exam was started. First, a
non-contrast-enhanced CT data acquisition with the following pa-
rameters was acquired: tube-rotation time 0.5 s/evolution; 140 kV;
80 mA; 22.5 mm/rotation; slice pitch 6 (high-speed mode); recon-
structed slice thickness 5 mm; scan length 867 mm; and acquisition
time 22.5 s per CT scan. The CT data were acquired during shal-
low breathing. After table transposition into the PET-sensitive field
of view, emission data were acquired at six incremental table posi-
tions, each 146 mm wide, thereby covering 867 mm of table travel.
For each position, 35 2D non-attenuation-corrected scans were 
obtained simultaneously over a 4-min period. The CT data was
used for attenuation correction [2]; therefore, data acquisition was
performed within 25 min covering the patient from the head to the
pelvic floor. Viewing of co-registered images was performed using
a dedicated software (eNTEGRA, Elgems, Haifa, Israel).
Fig. 1 Coronal positron emission tomography (PET) image in
case 1: pathological 2-[F-18]-fluoro-2-deoxy-D-glucose (FDG)
accumulation in the right apical lung is seen
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Fig. 2 Case 1. The FDG uptake in the tumor mass in the left upper lobe adjacent to the aorta
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Fig. 3 Case 1. The co-registered CT image corresponding to the PET
image showed no anatomical correlate to the FDG focus. The focus
projected onto a branching point of a peripheral lung vessel (arrow)
Fig. 4 Partially paravenous injection in the right arm in case 1
evidence. The advantage of FDG PET/CT in this setting
is that anatomy helps to specify the findings.
In conclusion, our data suggest that extra care with
FDG injection should be taken and aspiration of blood
should be avoided. When intrpreting the presence of
focal lesions in the lung field, a differential diagnosis of
a microembolism containing FDG has to be considered,
and if no corroborating anatomic evidence of the lesion
is found, this diagnosis is likely.
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Fig. 5a, b Case 1. a Coronal view of CT, PET, and PET/CT (left to right) demonstrating intrapulmonary FDG uptake in the right apical
upper lobe. b Control imaging 5 days after the first exam shows no evidence of pathologic FDG uptake
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Fig. 6 Case 2 with FDG accumulation in the right lung without
anatomic correlate (arrows)
Fig. 7 Case 3 with FDG accumulation in the right lung without
anatomic correlate (arrows)
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